Panos C.

Panos C. is an experienced professional in the field of biotechnology and cell therapy, currently serving as the Chief Development Officer at Morphocell Technologies and Co-Founder & Director at weCANdev Consulting Group Inc. Since March 2021, Panos held senior leadership roles at Artisan Biotechnologies, focusing on process and analytical development for cell therapies, particularly in CRISPR-based gene editing and CAR-T cell therapy. Previous positions include Associate Director at BlueRock Therapeutics and various roles at CCRM, Griffith University, and The University of Queensland, where Panos contributed to significant advancements in cell and gene therapies, metabolomics, and proteomics. Panos holds a Ph.D. in Biomedical Engineering from The University of Queensland and a BSc in Biology from the University of Patras.